180 related articles for article (PubMed ID: 8821739)
61. L-proline activates glutamate and glycine receptors in cultured rat dorsal horn neurons.
Henzi V; Reichling DB; Helm SW; MacDermott AB
Mol Pharmacol; 1992 Apr; 41(4):793-801. PubMed ID: 1349155
[TBL] [Abstract][Full Text] [Related]
62. Bis(7)-tacrine prevents glutamate-induced excitotoxicity more potently than memantine by selectively inhibiting NMDA receptors.
Liu YW; Li CY; Luo JL; Li WM; Fu HJ; Lao YZ; Liu LJ; Pang YP; Chang DC; Li ZW; Peoples RW; Ai YX; Han YF
Biochem Biophys Res Commun; 2008 May; 369(4):1007-11. PubMed ID: 18328812
[TBL] [Abstract][Full Text] [Related]
63. Selective blockade of non-NMDA receptors does not block rapidly triggered glutamate-induced neuronal death.
Koh JY; Choi DW
Brain Res; 1991 May; 548(1-2):318-21. PubMed ID: 1678302
[TBL] [Abstract][Full Text] [Related]
64. Cyclooxygenase-2 inhibition protects cultured cerebellar granule neurons from glutamate-mediated cell death.
Strauss KI; Marini AM
J Neurotrauma; 2002 May; 19(5):627-38. PubMed ID: 12042097
[TBL] [Abstract][Full Text] [Related]
65. NMDA receptor-mediated neurotoxicity: a paradoxical requirement for extracellular Mg2+ in Na+/Ca2+-free solutions in rat cortical neurons in vitro.
Hartnett KA; Stout AK; Rajdev S; Rosenberg PA; Reynolds IJ; Aizenman E
J Neurochem; 1997 May; 68(5):1836-45. PubMed ID: 9109508
[TBL] [Abstract][Full Text] [Related]
66. Influence of some convulsant agents on the protective activity of a novel antiepileptic drug, felbamate, against maximal electroshock in mice.
Swiader M; Gasior M; Wielosz M; Czuczwar SJ
Pol J Pharmacol; 2003; 55(4):649-53. PubMed ID: 14581726
[TBL] [Abstract][Full Text] [Related]
67. Mechanisms involved in the metabotropic glutamate receptor-enhancement of NMDA-mediated motoneurone responses in frog spinal cord.
Holohean AM; Hackman JC; Davidoff RA
Br J Pharmacol; 1999 Jan; 126(1):333-41. PubMed ID: 10051153
[TBL] [Abstract][Full Text] [Related]
68. E-p-methoxycinnamic acid protects cultured neuronal cells against neurotoxicity induced by glutamate.
Kim SR; Sung SH; Jang YP; Markelonis GJ; Oh TH; Kim YC
Br J Pharmacol; 2002 Mar; 135(5):1281-91. PubMed ID: 11877337
[TBL] [Abstract][Full Text] [Related]
69. Glutamate receptor agonists modulate [Ca2+]i in isolated rat melanotropes.
Giovannucci DR; Stuenkel EL
Neuroendocrinology; 1995 Aug; 62(2):111-22. PubMed ID: 8584110
[TBL] [Abstract][Full Text] [Related]
70. The severity of naloxone-precipitated opiate withdrawal is attenuated by felbamate, a possible glycine antagonist.
Kosten TA; DeCaprio JL; Rosen MI
Neuropsychopharmacology; 1995 Dec; 13(4):323-33. PubMed ID: 8747757
[TBL] [Abstract][Full Text] [Related]
71. Antagonism of convulsions but failure to enhance GABA(A) receptor function by felbamate in mice tolerant to diazepam.
Serra M; Cuccu R; Ghiani CA; Pisu MG; Murgia A; Biggio G
Neurochem Res; 1997 Jun; 22(6):693-7. PubMed ID: 9178952
[TBL] [Abstract][Full Text] [Related]
72. D-aspartate and NMDA, but not L-aspartate, block AMPA receptors in rat hippocampal neurons.
Gong XQ; Frandsen A; Lu WY; Wan Y; Zabek RL; Pickering DS; Bai D
Br J Pharmacol; 2005 Jun; 145(4):449-59. PubMed ID: 15806114
[TBL] [Abstract][Full Text] [Related]
73. Transforming growth factor-beta2 increases NMDA receptor-mediated excitotoxicity in rat cerebral cortical neurons independently of glia.
Kane CJ; Brown GJ; Phelan KD
Neurosci Lett; 1996 Feb; 204(1-2):93-6. PubMed ID: 8929986
[TBL] [Abstract][Full Text] [Related]
74. Glycine reversal of felbamate hypoxic protection.
Wallis RA; Panizzon KL
Neuroreport; 1993 Jul; 4(7):951-4. PubMed ID: 8103685
[TBL] [Abstract][Full Text] [Related]
75. NMDA receptor coagonist glycine site: evidence for a role in lateral hypothalamic stimulation of feeding.
Stanley BG; Butterfield BS; Grewal RS
Am J Physiol; 1997 Aug; 273(2 Pt 2):R790-6. PubMed ID: 9277570
[TBL] [Abstract][Full Text] [Related]
76. Positive and negative modulation by AMPA- and kainate-receptors of striatal kainate injection-induced neuronal loss in rat forebrain.
Zhu X; Jin S; Ng YK; Lee WL; Wong PT
Brain Res; 2001 Dec; 922(2):293-8. PubMed ID: 11743962
[TBL] [Abstract][Full Text] [Related]
77. Sustained exposure to 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, alters N-methyl-D-aspartate receptor function and subunit composition.
Fossom LH; Basile AS; Skolnick P
Mol Pharmacol; 1995 Dec; 48(6):981-7. PubMed ID: 8848014
[TBL] [Abstract][Full Text] [Related]
78. Felbamate neuroprotection against CA1 traumatic neuronal injury.
Wallis RA; Panizzon KL
Eur J Pharmacol; 1995 Dec; 294(2-3):475-82. PubMed ID: 8750708
[TBL] [Abstract][Full Text] [Related]
79. Reduction of dizocilpine and scopolamine-induced deficits in avoidance responding by SCH 54388, a metabolite of felbamate.
Smith RD; Grzelak ME; Coffin VL
Pharmacol Biochem Behav; 1997 Nov; 58(3):657-64. PubMed ID: 9329055
[TBL] [Abstract][Full Text] [Related]
80. Strychnine-insensitive glycine site antagonists attenuate a cardiac arrest-induced movement disorder.
Matsumoto RR; Nguyen D; Truong DD
Eur J Pharmacol; 1995 Mar; 275(2):117-23. PubMed ID: 7796845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
